AbbVie Inc (ABBV)
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid.
AbbVie SEC Filing Email Alerts Service
Company Name: |
AbbVie Inc |
Stock buyback: |
ABBV buyback |
Website: |
www.abbvie.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding ABBV: |
132 |
Total Market Value Held by ETFs: |
$37.98B |
Total Market Capitalization: |
$289.99B |
% of Market Cap. Held by ETFs: |
13.10% |
|
|
April 19, 2024 3:45 PM Eastern
Buy (3.17 out of 4)
100th percentile
|
|